<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25421478</PMID><DateCompleted><Year>2015</Year><Month>12</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-6596</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Antimicrobial agents and chemotherapy</Title><ISOAbbreviation>Antimicrob Agents Chemother</ISOAbbreviation></Journal><ArticleTitle>Biochemical characterization of recombinant Enterovirus 71 3C protease with fluorogenic model peptide substrates and development of a biochemical assay.</ArticleTitle><Pagination><StartPage>1827</StartPage><EndPage>1836</EndPage><MedlinePgn>1827-36</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/AAC.04698-14</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71), a primary pathogen of hand, foot, and mouth disease (HFMD), affects primarily infants and children. Currently, there are no effective drugs against HFMD. EV71 3C protease performs multiple tasks in the viral replication, which makes it an ideal antiviral target. We synthesized a small set of fluorogenic model peptides derived from cleavage sites of EV71 polyprotein and examined their efficiencies of cleavage by EV71 3C protease. The novel peptide P08 [(2-(N-methylamino)benzoyl) (NMA)-IEALFQGPPK(DNP)FR] was determined to be the most efficiently cleaved by EV71 3C protease, with a kinetic constant kcat/Km of 11.8 &#xb1; 0.82 mM(-1) min(-1). Compared with literature reports, P08 gave significant improvement in the signal/background ratio, which makes it an attractive substrate for assay development. A Molecular dynamics simulation study elaborated the interactions between substrate P08 and EV71 3C protease. Arg39, which is located at the bottom of the S2 pocket of EV71 3C protease, may participate in the proteolysis process of substrates. With an aim to evaluate EV71 3C protease inhibitors, a reliable and robust biochemical assay with a Z' factor of 0.87 &#xb1; 0.05 was developed. A novel compound (compound 3) (50% inhibitory concentration [IC50] = 1.89 &#xb1; 0.25 &#x3bc;M) was discovered using this assay, which effectively suppressed the proliferation of EV 71 (strain Fuyang) in rhabdomyosarcoma (RD) cells with a highly selective index (50% effective concentration [EC50] = 4.54 &#xb1; 0.51 &#x3bc;M; 50% cytotoxic concentration [CC50] &gt; 100 &#x3bc;M). This fast and efficient assay for lead discovery and optimization provides an ideal platform for anti-EV71 drug development targeting 3C protease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015, American Society for Microbiology. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Luqing</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>College of Pharmacy &amp; State Key Laboratory of Elemento-Organic Chemistry, Nankai University, Tianjin, People's Republic of China Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Tianjin, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shumei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>College of Pharmacy &amp; State Key Laboratory of Elemento-Organic Chemistry, Nankai University, Tianjin, People's Republic of China Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Tianjin, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>College of Pharmacy &amp; State Key Laboratory of Elemento-Organic Chemistry, Nankai University, Tianjin, People's Republic of China Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Tianjin, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Jixue</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Pharmacy &amp; State Key Laboratory of Elemento-Organic Chemistry, Nankai University, Tianjin, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Linfeng</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>College of Pharmacy &amp; State Key Laboratory of Elemento-Organic Chemistry, Nankai University, Tianjin, People's Republic of China Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Tianjin, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Zhengjie</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>College of Pharmacy &amp; State Key Laboratory of Elemento-Organic Chemistry, Nankai University, Tianjin, People's Republic of China Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Tianjin, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Qiuhong</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>High-Throughput Molecular Drug Discovery Center, Tianjin International Joint Academy of Biotechnology &amp; Medicine, Tianjin, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Pharmacy &amp; State Key Laboratory of Elemento-Organic Chemistry, Nankai University, Tianjin, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yuna</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Science, Beijing, People's Republic of China sunyn@moon.ibp.ac.cn zheng_yin@nankai.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>College of Pharmacy &amp; State Key Laboratory of Elemento-Organic Chemistry, Nankai University, Tianjin, People's Republic of China Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Tianjin, People's Republic of China sunyn@moon.ibp.ac.cn zheng_yin@nankai.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>11</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Antimicrob Agents Chemother</MedlineTA><NlmUniqueID>0315061</NlmUniqueID><ISSNLinking>0066-4804</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005456">Fluorescent Dyes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011480">Protease Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.28</RegistryNumber><NameOfSubstance UI="D000086042">3C Viral Proteases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086042" MajorTopicYN="N">3C Viral Proteases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001681" MajorTopicYN="N">Biological Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005456" MajorTopicYN="N">Fluorescent Dyes</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029544" MajorTopicYN="N">Foot-and-Mouth Disease Virus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011480" MajorTopicYN="N">Protease Inhibitors</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013379" MajorTopicYN="N">Substrate Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25421478</ArticleId><ArticleId IdType="pmc">PMC4356770</ArticleId><ArticleId IdType="doi">10.1128/AAC.04698-14</ArticleId><ArticleId IdType="pii">AAC.04698-14</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chan KP, Goh KT, Chong CY, Teo ES, Lau G, Ling AE. 2003. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis 9:78&#x2013;85. doi:10.3201/eid1301.020112.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1301.020112</ArticleId><ArticleId IdType="pmc">PMC2873753</ArticleId><ArticleId IdType="pubmed">12533285</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Wang H, Gong E, Du J, Zhao X, McNutt MA, Wang S, Zhong Y, Gao Z, Zheng J. 2009. Neuropathology in 2 cases of fatal enterovirus type 71 infection from a recent epidemic in the People's Republic of China: a histopathologic, immunohistochemical, and reverse transcription polymerase chain reaction study. Hum Pathol 40:1288&#x2013;1295. doi:10.1016/j.humpath.2009.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humpath.2009.01.015</ArticleId><ArticleId IdType="pubmed">19386354</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S-C, Chang H-L, Yan T-R, Cheng Y-T, Chen K-T. 2007. An eight-year study of epidemiologic features of enterovirus 71 infection in Taiwan. Am J Trop Med Hyg 77:188&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">17620652</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua K, Chua B, Lee C, Chem Y, Ismail N, Kiyu A, Kumarasamy V. 2007. Genetic diversity of enterovirus 71 isolated from cases of hand, foot and mouth disease in the 1997, 2000 and 2005 outbreaks, Peninsular Malaysia. Malays J Pathol 29:69&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">19108398</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Wang Y, Shan C, Sun Y, Xu P, Zhou H, Yang C, Shi P-Y, Rao Z, Zhang B. 2013. Crystal structure of enterovirus 71 RNA-dependent RNA polymerase complexed with its protein primer VPg: implication for a trans mechanism of VPg uridylylation. J Virol 87:5755&#x2013;5768. doi:10.1128/JVI.02733-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02733-12</ArticleId><ArticleId IdType="pmc">PMC3648134</ArticleId><ArticleId IdType="pubmed">23487447</ArticleId></ArticleIdList></Reference><Reference><Citation>Ming Z, Wang W, Xie Y, Ding P, Chen Y, Jin D, Sun Y, Xia B, Yan L, Lou Z. 2014. Crystal structure of the novel di-nucleotide cyclase from Vibrio cholerae (DncV) responsible for synthesizing a hybrid cyclic GMP-AMP. Cell Res 24:1270&#x2013;1273. doi:10.1038/cr.2014.123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2014.123</ArticleId><ArticleId IdType="pmc">PMC4185349</ArticleId><ArticleId IdType="pubmed">25245040</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Guo Y, Lou Z. 2014. Formation and working mechanism of the picornavirus VPg uridylylation complex. Curr Opin Virol 9:24&#x2013;30. doi:10.1016/j.coviro.2014.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2014.09.003</ArticleId><ArticleId IdType="pubmed">25240314</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong P, Kortus MG, Nix JC, Davis RE, Peersen OB. 2013. Structures of coxsackievirus, rhinovirus, and poliovirus polymerase elongation complexes solved by engineering RNA mediated crystal contacts. PLoS One 8:e60272. doi:10.1371/journal.pone.0060272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0060272</ArticleId><ArticleId IdType="pmc">PMC3648537</ArticleId><ArticleId IdType="pubmed">23667424</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26:91&#x2013;107. doi:10.1111/j.1574-6976.2002.tb00601.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2002.tb00601.x</ArticleId><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Lou Z, Miao Y, Yu Y, Dong H, Peng W, Bartlam M, Li X, Rao Z. 2010. Structures of EV71 RNA-dependent RNA polymerase in complex with substrate and analogue provide a drug target against the hand-foot-and-mouth disease pandemic in China. Protein Cell 1:491&#x2013;500. doi:10.1007/s13238-010-0061-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-010-0061-7</ArticleId><ArticleId IdType="pmc">PMC4875138</ArticleId><ArticleId IdType="pubmed">21203964</ArticleId></ArticleIdList></Reference><Reference><Citation>Qing J, Wang Y, Sun Y, Huang J, Yan W, Wang J, Su D, Ni C, Li J, Rao Z. 2014. Cyclophilin a associates with enterovirus-71 virus capsid and plays an essential role in viral infection as an uncoating regulator. PLoS Pathol 10:e1004422. doi:10.1371/journal.ppat.1004422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004422</ArticleId><ArticleId IdType="pmc">PMC4183573</ArticleId><ArticleId IdType="pubmed">25275585</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang Y-C, Chen W, Yates MV. 2006. Use of fluorescence resonance energy transfer for rapid detection of enteroviral infection in vivo. Appl Environ Microbiol 72:3710&#x2013;3715. doi:10.1128/AEM.72.5.3710-3715.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.72.5.3710-3715.2006</ArticleId><ArticleId IdType="pmc">PMC1472337</ArticleId><ArticleId IdType="pubmed">16672521</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop NE, Anderson DA. 1993. RNA-dependent cleavage of VP0 capsid protein in provirions of hepatitis A virus. Virology 197:616&#x2013;623. doi:10.1006/viro.1993.1636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1993.1636</ArticleId><ArticleId IdType="pubmed">8249284</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcotte LL, Wass AB, Gohara DW, Pathak HB, Arnold JJ, Filman DJ, Cameron CE, Hogle JM. 2007. Crystal structure of poliovirus 3CD protein: virally encoded protease and precursor to the RNA-dependent RNA polymerase. J Virol 81:3583&#x2013;3596. doi:10.1128/JVI.02306-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02306-06</ArticleId><ArticleId IdType="pmc">PMC1866080</ArticleId><ArticleId IdType="pubmed">17251299</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews DA, Smith WW, Ferre RA, Condon B, Budahazi G, Slsson W, Villafranca J, Janson CA, McElroy H, Gribskov C. 1994. Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein. Cell 77:761&#x2013;771. doi:10.1016/0092-8674(94)90059-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(94)90059-0</ArticleId><ArticleId IdType="pubmed">7515772</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Wang Y, Shan C, Chen C, Xu P, Song M, Zhou H, Yang C, Xu W, Shi P-Y. 2012. Enterovirus 71 VPg uridylation uses a two-molecular mechanism of 3D polymerase. J Virol 86:13662&#x2013;13671. doi:10.1128/JVI.01712-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01712-12</ArticleId><ArticleId IdType="pmc">PMC3503026</ArticleId><ArticleId IdType="pubmed">23055549</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng K-F, Li M-L, Hung C-T, Shih S-R. 2009. Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathol 5:e1000593. doi:10.1371/journal.ppat.1000593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000593</ArticleId><ArticleId IdType="pmc">PMC2742901</ArticleId><ArticleId IdType="pubmed">19779565</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark ME, H&#xe4;mmerle T, Wimmer E, Dasgupta A. 1991. Poliovirus proteinase 3C converts an active form of transcription factor IIIC to an inactive form: a mechanism for inhibition of host cell polymerase III transcription by poliovirus. EMBO J 10:2941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC453008</ArticleId><ArticleId IdType="pubmed">1915271</ArticleId></ArticleIdList></Reference><Reference><Citation>Falk M, Grigera P, Bergmann I, Zibert A, Multhaup G, Beck E. 1990. Foot-and-mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3. J Virol 64:748&#x2013;756.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC249169</ArticleId><ArticleId IdType="pubmed">2153239</ArticleId></ArticleIdList></Reference><Reference><Citation>Weidman MK, Yalamanchili P, Ng B, Tsai W, Dasgupta A. 2001. Poliovirus 3C protease-mediated degradation of transcriptional activator p53 requires a cellular activity. Virology 291:260&#x2013;271. doi:10.1006/viro.2001.1215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2001.1215</ArticleId><ArticleId IdType="pubmed">11878895</ArticleId></ArticleIdList></Reference><Reference><Citation>Yalamanchili P, Datta U, Dasgupta A. 1997. Inhibition of host cell transcription by poliovirus: cleavage of transcription factor CREB by poliovirus-encoded protease 3Cpro. J Virol 71:1220&#x2013;1226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC191176</ArticleId><ArticleId IdType="pubmed">8995645</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang L, Xu M, Yin Z. 2013. Antiviral drug discovery for the treatment of enterovirus 71 infections. Antiviral Res 97:183&#x2013;194. doi:10.1016/j.antiviral.2012.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.12.005</ArticleId><ArticleId IdType="pubmed">23261847</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui S, Wang J, Fan T, Qin B, Guo L, Lei X, Wang J, Wang M, Jin Q. 2011. Crystal structure of human enterovirus 71 3C protease. J Mol Biol 408:449&#x2013;461. doi:10.1016/j.jmb.2011.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2011.03.007</ArticleId><ArticleId IdType="pmc">PMC7094522</ArticleId><ArticleId IdType="pubmed">21396941</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Fan T, Yao X, Wu Z, Guo L, Lei X, Wang J, Wang M, Jin Q, Cui S. 2011. Crystal structures of enterovirus 71 3C protease complexed with rupintrivir reveal the roles of catalytically important residues. J Virol 85:10021&#x2013;10030. doi:10.1128/JVI.05107-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05107-11</ArticleId><ArticleId IdType="pmc">PMC3196404</ArticleId><ArticleId IdType="pubmed">21813612</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu G, Qi J, Chen Z, Xu X, Gao F, Lin D, Qian W, Liu H, Jiang H, Yan J. 2011. Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design. J Virol 85:10319&#x2013;10331. doi:10.1128/JVI.00787-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00787-11</ArticleId><ArticleId IdType="pmc">PMC3196414</ArticleId><ArticleId IdType="pubmed">21795339</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo C-J, Shie J-J, Fang J-M, Yen G-R, Hsu JT-A, Liu H-G, Tseng S-N, Chang S-C, Lee C-Y, Shih S-R. 2008. Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents. Bioorg Med Chem 16:7388&#x2013;7398. doi:10.1016/j.bmc.2008.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2008.06.015</ArticleId><ArticleId IdType="pmc">PMC7125518</ArticleId><ArticleId IdType="pubmed">18583140</ArticleId></ArticleIdList></Reference><Reference><Citation>Haugland RP, Yguerabide J, Stryer L. 1969. Dependence of the kinetics of singlet-singlet energy transfer on spectral overlap. Proc Natl Acad Sci U S A 63:23&#x2013;30. doi:10.1073/pnas.63.1.23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.63.1.23</ArticleId><ArticleId IdType="pmc">PMC534026</ArticleId><ArticleId IdType="pubmed">16591747</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Wang Q, Pan X, de Castro IF, Sun Y, Guo Y, Tao X, Risco C, Sui S-F, Lou Z. 2013. Bunyamwera virus possesses a distinct nucleocapsid protein to facilitate genome encapsidation. Proc Natl Acad Sci U S A 110:9048&#x2013;9053. doi:10.1073/pnas.1222552110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222552110</ArticleId><ArticleId IdType="pmc">PMC3670369</ArticleId><ArticleId IdType="pubmed">23569257</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Cai Q, Chen C, Li N, Peng X, Cai Y, Yin K, Chen X, Wang X, Zhang R. 2013. Structures of enterovirus 71 3C proteinase (strain E2004104-TW-CDC) and its complex with rupintrivir. Acta Crystallogr Sect D Biol Crystallogr 69:866&#x2013;871. doi:10.1107/S0907444913002862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444913002862</ArticleId><ArticleId IdType="pubmed">23633597</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Wang W, Ji W, Deng M, Sun Y, Zhou H, Yang C, Deng F, Wang H, Hu Z. 2012. Crimean-Congo hemorrhagic fever virus nucleoprotein reveals endonuclease activity in bunyaviruses. Proc Natl Acad Sci U S A 109:5046&#x2013;5051. doi:10.1073/pnas.1200808109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1200808109</ArticleId><ArticleId IdType="pmc">PMC3324003</ArticleId><ArticleId IdType="pubmed">22421137</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirata IY, Cezari MHS, Nakaie CR, Boschcov P, Ito AS, Juliano MA, Juliano L. 1995. Internally quenched fluorogenic protease substrates: solid-phase synthesis and fluorescence spectroscopy of peptides containing ortho-aminobenzoyl/dinitrophenyl groups as donor-acceptor pairs. Lett Pept Sci 1:299&#x2013;308. doi:10.1007/BF00119771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00119771</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J-H, Chung TD, Oldenburg KR. 1999. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4:67&#x2013;73. doi:10.1177/108705719900400206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/108705719900400206</ArticleId><ArticleId IdType="pubmed">10838414</ArticleId></ArticleIdList></Reference><Reference><Citation>Klauda JB, Brooks BR. 2008. CHARMM force field parameters for nitroalkanes and nitroarenes. J Chem Theor Comput 4:107&#x2013;115. doi:10.1021/ct700191v.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ct700191v</ArticleId><ArticleId IdType="pubmed">26619984</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche O, Kiyama R, Brooks CL. 2001. Ligand-protein database: linking protein-ligand complex structures to binding data. J Med Chem 44:3592&#x2013;3598. doi:10.1021/jm000467k.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm000467k</ArticleId><ArticleId IdType="pubmed">11606123</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. 1983. Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926&#x2013;935. doi:10.1063/1.445869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1063/1.445869</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastor RW, Brooks BR, Szabo A. 1988. An analysis of the accuracy of Langevin and molecular dynamics algorithms. Mol Phys 65:1409&#x2013;1419. doi:10.1080/00268978800101881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00268978800101881</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang L, Wang Y, Qing J, Shu B, Cao L, Lou Z, Gong P, Sun Y, Yin Z. 2014. An adenosine nucleoside analogue NITD008 inhibits EV71 proliferation. Antiviral Res 112:47&#x2013;58. doi:10.1016/j.antiviral.2014.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2014.10.009</ArticleId><ArticleId IdType="pubmed">25446894</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Lawson HL, Harish VC, Huff JD, Knovich MA, Owen J. 2006. Creation of a recombinant peptide substrate for fluorescence resonance energy transfer-based protease assays. Anal Biochem 358:298&#x2013;300. doi:10.1016/j.ab.2006.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ab.2006.06.022</ArticleId><ArticleId IdType="pubmed">16876104</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouvea I, Izidoro M, Judice W, Cezari M, Caliendo G, Santagada V, Dos Santos C, Queiroz M, Juliano M, Young P. 2007. Substrate specificity of recombinant dengue 2 virus NS2B-NS3 protease: influence of natural and unnatural basic amino acids on hydrolysis of synthetic fluorescent substrates. Arch Biochem Biophys 457:187&#x2013;196. doi:10.1016/j.abb.2006.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2006.11.005</ArticleId><ArticleId IdType="pubmed">17184724</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou Z, Sun Y, Rao Z. 2014. Current progress in antiviral strategies. Trends Pharmacol Sci 35:86&#x2013;102. doi:10.1016/j.tips.2013.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2013.11.006</ArticleId><ArticleId IdType="pmc">PMC7112804</ArticleId><ArticleId IdType="pubmed">24439476</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiryaev SA, Ratnikov BI, Aleshin AE, Kozlov IA, Nelson NA, Lebl M, Smith JW, Liddington RC, Strongin AY. 2007. Switching the substrate specificity of the two-component NS2B-NS3 flavivirus proteinase by structure-based mutagenesis. J Virol 81:4501&#x2013;4509. doi:10.1128/JVI.02719-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02719-06</ArticleId><ArticleId IdType="pmc">PMC1900165</ArticleId><ArticleId IdType="pubmed">17301157</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai M-T, Cheng Y-H, Liu Y-N, Liao N-C, Lu W-W, Kung S-H. 2009. Real-time monitoring of human enterovirus (HEV)-infected cells and anti-HEV 3C protease potency by fluorescence resonance energy transfer. Antimicrob Agents Chemother 53:748&#x2013;755. doi:10.1128/AAC.00841-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00841-08</ArticleId><ArticleId IdType="pmc">PMC2630644</ArticleId><ArticleId IdType="pubmed">19015331</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Sun Y, Guo Y, Lou Z. 2013. Structural perspective on the formation of ribonucleoprotein complex in negative-sense single-stranded RNA viruses. Trends Microbiol 21:475&#x2013;484. doi:10.1016/j.tim.2013.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2013.07.006</ArticleId><ArticleId IdType="pubmed">23953596</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryckaert J-P, Ciccotti G, Berendsen HJC. 1977. Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys 23:327&#x2013;341. doi:10.1016/0021-9991(77)90098-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9991(77)90098-5</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>